ResMed's GAAP net income for nine months of fiscal 2021 was $279.405 million, down 37% from $443.839 million in the prior year. Revenue increased 6.1% to $2.321 billion compared to $2.187 billion a year earlier.
ResMed's GAAP net income for nine months of fiscal 2021 was $279.405 million, down 37% from $443.839 million in the prior year. Revenue increased 6.1% to $2.321 billion compared to $2.187 billion a year earlier. 
investors.resmed.com
English (US) 